Skip Navigation U.S. Department of Health and Human Services www.hhs.gov/
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov/

Drugs, Pharmaceuticals, and Therapeutics

Research Findings


Research Activities: Online Newsletter 
Summarizes study findings, including those specific or relevant to drugs, pharmaceuticals, and therapeutics

Top of Page Top of Page

Resources

Advancing Pharmacy Health Literacy Practices Through Quality Improvement: Curricular Modules for Faculty
Blood Thinner Pills: Using Them Safely
Medications at Transitions and Clinical Handoffs (MATCH) Toolkit for Medication Reconciliation
Outcomes of Pharmaceutical Outcomes Research—Impact of Studies Funded: Final Report
Outcomes of Pharmaceutical Therapy: Program Update
Pharmacy Health Literacy Center
   Automated Telephone Reminders
   How to Create a Pill Card
   Is Our Pharmacy Meeting Patients' Needs? A Pharmacy Health Literacy Assessment Tool User's Guide
   Strategies To Improve Communication Between Pharmacy Staff and Patients
Prescription Drug Therapies: Reducing Costs and Improving Outcomes
Quick Tips—When Getting a Prescription
Your Medicine: Be Smart. Be Safe. (en español)

Top of Page Top of Page

Centers for Education and Research on Therapeutics (CERTs)

CERTs Web Site
CERTs Overview: Fact Sheet
Nominations of Topics for Research on Therapeutics
Preventable Adverse Drug Reactions: A Focus on Drug Interactions

Top of Page Top of Page

Comparative Effectiveness Reviews

Comparative Effectiveness Review, No. 3:
Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment
Comparative Effectiveness Review, No. 4:
Comparative Effectiveness and Safety of Analgesics for Osteoarthritis
Comparative Effectiveness Review, No. 6:
Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics
Comparative Effectiveness Review, No. 7:
Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Comparative Effectiveness Review, No. 8:
Comparative Effectiveness and Safety of Oral Diabetes Medications for Adults With Type 2 Diabetes
Comparative Effectiveness Review, No. 10:
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension
Comparative Effectiveness Review, No. 11:
Comparative Effectiveness of Drug Therapy for Rheumatoid Arthritis and Psoriatic Arthritis in Adults

Comparative Effectiveness Review, No. 51:
Dietary Supplements in Adults Taking Cardiovascular Drugs
Comparative Effectiveness Review, No. 55:
Drug Therapy for Rheumatoid Arthritis in Adults: An Update

Top of Page Top of Page

Evidence Reports

Evidence Report/Technology Assessment, No. 196:
Assessment of Thiopurine Methyltransferase Activity in Patients Prescribed Azathioprine or Other Thiopurine-based Drugs

Top of Page Top of Page

Medical Expenditure Panel Survey (MEPS) Reports

MEPS Chartbook, Number 16
Outpatient Prescription Drug Expenses in the U.S. Community Population, 2003 (PDF File, 397 KB; Plugin Software Help)
MEPS Research Findings, Number 25
Trends in the Pharmaceutical Treatment of Hypertension, 1997 to 2003 (PDF File, 1.6 MB; Plugin Software Help)
MEPS Statistical Brief, Number 58:
Chronic Conditions and Outpatient Prescription Medicines for Persons 18 and Older in the U.S. Civilian Noninstitutionalized Population, 1987 and 2001 (PDF File, 155 KB; Plugin Software Help)
MEPS Statistical Brief, Number 102:
Prescription Drugs: Out-of-Pocket Expenses and Unmet Need Relative to Family Income, 2002 (PDF File, 90 KB; Plugin Software Help)
MEPS Statistical Brief, Number 139:
Trends in the Use and Expenditures for COX-2 Inhibitors and Traditional Nonsteroidal Anti-inflammatory Drugs, 1997-2003 (PDF File, 105 KB; Plugin Software Help)
MEPS Statistical Brief, Number 144:
Trends in Brand Name and Generic Prescribed Medicine Utilization and Expenditures, 1999 and 2003 (PDF File, 85 KB; Plugin Software Help)
MEPS Statistical Brief, Number 154:
The Top Five Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2004 (PDF File, 98 KB; Plugin Software Help)
MEPS Statistical Brief, Number 158:
Prescription Drug Expenditures in the 10 Largest States for Persons under Age 65, 2004 (PDF File, 107 KB; Plugin Software Help)
MEPS Statistical Brief, Number 163:
Trends in the Use and Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and All Subclasses, 1997 and 2004 (PDF File, 106 KB; Plugin Software Help)
MEPS Statistical Brief, Number 179:
Aspirin Use among the Adult U.S. Noninstitutionalized Population, with and without Indicators of Heart Disease, 2005 (PDF File, 114 KB; Plugin Software Help)
MEPS Statistical Brief, Number 313:
Expenditures for the Top Five Classes of Outpatient Prescription Drugs, Adult ages 18 and Older, 2008

Top of Page Top of Page

 

AHRQAdvancing Excellence in Health Care